Name: TLX TLX101-Px Catalyst
Start: 2026-03-16

Telix Pharmaceuticals Ltd

Catalyst Confirmed

TLX101-Px

glioma

Resolved

113days ago

Catalyst readout · Mar 16, 2026

What's at stake A key catalyst for TLX101-Px (glioma) is expected Mar 16, 2026.

Primary source · SEC 6-K verified 12h ago

“Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate”

1 source on file.

Link copied ✓